Crystagen (EDP)
Also known as Crystagen · EDP · Glu-Asp-Pro · Kristagen · T-38
New
Reconstitution & dosing guide
20 mg vial — research phases, recon steps, and a live unit calculator.
Available sizes & price
Catalog only20mg x 10 vials
Crystagen · Not in current stock
$45 / vial
Prices per vial · Research use only · Not medical advice.
Khavinson immune/thymus-focused short peptide bioregulator commonly cited as Glu-Asp-Pro (EDP), positioned as a synthetic counterpart within the thymic bioregulator family alongside Thymalin.
How to picture it
An immune-organ bioregulator concept — a short peptide studied for immune competence and thymic-related signaling language. Not broad suppression, not a crude stimulant; more like a training reminder for immune coordination. Attractive in aging-immunity research aiming for smarter function.
Research focus & benefits
- Immune bioregulator research
- Thymic and immune-competence interest
- Aging-immunity short-peptide studies
Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.
Overview
Crystagen is marketed within the Khavinson catalog as the immune-system tissue bioregulator. Sequence citations vary slightly in secondary literature (EDP tripeptide is most common). Primary peer-reviewed footprint is thinner than Epitalon or Thymalin; effects are framed around T/B-cell balance, thymic involution, and immunosenescence.
Mechanism
Proposed tissue-selective epigenetic regulation of thymic and immune cell gene expression. Organotypic spleen studies associate EDP with B-cell compartment activation; observational clinical descriptions claim normalized CD4/CD8 ratios and reduced infection frequency in aging cohorts (single-group literature quality).
Research uses
- Thymocyte and lymphocyte signal-transduction studies
- Age-related immune decline models
- Comparative short-peptide immune bioregulator panels
Research dosing notes
Bioregulator cyclic courses. Not interchangeable with pharmaceutical thymic hormones.
Half-life / kinetics
Short (tripeptide)
Common research routes
Reported considerations
- Limited Western RCT data
- Theoretical immune stimulation concerns in autoimmunity
Contraindications / cautions
- Active autoimmune flare without specialist guidance
- Transplant immunosuppression contexts
- Pregnancy
Common research stacks
- Thymosin Alpha-1
- Thymalin
- Vilon
- Epitalon
Legal / access note
Research bioregulator; not FDA-approved for immune deficiency or infection prevention.